Skip to content

OLEMA PHARMACEUTICALS, INC.

OLMA

CIK 0001750284

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$169.48M
−25.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.88
+15.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$134.47M
Q1 May 2026
Cash
$52.55M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
87.35M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings